Bioregenx, Inc. financial data

Symbol
BRGX on OTC
Industry
Services-Computer Programming, Data Processing, Etc.
Location
7407 Ziegler Road, Chattanooga, TN
State of incorporation
NV
Fiscal year end
December 31
Former names
FINDIT, INC. (to 1/18/2024), ARTEMIS ENERGY HOLDINGS, INC. (to 12/11/2013)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 14 % +3672%
Quick Ratio 5.6 %
Debt-to-equity 34.2 %
Return On Equity -25.4 % -120%
Return On Assets -18.9 % +99.6%
Operating Margin 163 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 957M shares
Common Stock, Shares, Outstanding 957M shares +246%
Entity Public Float 4.24M USD +351%
Common Stock, Value, Issued 957K USD +246%
Weighted Average Number of Shares Outstanding, Basic 957M shares +53.8%
Weighted Average Number of Shares Outstanding, Diluted 957M shares +53.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues -832K USD -130%
Cost of Revenue 114K USD -48.8%
Research and Development Expense 0 USD -100%
Operating Income (Loss) -1.36M USD +57.6%
Nonoperating Income (Expense) -522K USD -258%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.75M USD -546%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.59M USD +22.8%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70.1K USD
Accounts Receivable, after Allowance for Credit Loss, Current 19.4K USD
Inventory, Net 159K USD
Other Assets, Current 73.3K USD
Assets, Current 371K USD +48850%
Property, Plant and Equipment, Net 213K USD
Intangible Assets, Net (Excluding Goodwill) 17.1M USD
Goodwill 7.11M USD
Other Assets, Noncurrent 0 USD
Assets 17.4M USD +50991%
Accounts Payable, Current 493K USD
Accrued Liabilities, Current 427K USD
Liabilities, Current 3.52M USD +1363%
Liabilities 3.8M USD +1480%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.94K USD
Retained Earnings (Accumulated Deficit) -17.2M USD -391%
Stockholders' Equity Attributable to Parent 13.6M USD
Liabilities and Equity 17.4M USD +50991%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -104K USD +69%
Net Cash Provided by (Used in) Financing Activities 283K USD +71.5%
Net Cash Provided by (Used in) Investing Activities -191K USD
Common Stock, Shares Authorized 1.5B shares +200%
Common Stock, Shares, Issued 957M shares +246%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.2K USD +93.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 70.1K USD +20.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 737K USD +20.2%
Payments to Acquire Property, Plant, and Equipment 189K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.92M USD +42.2%
Deferred Tax Assets, Operating Loss Carryforwards 737K USD +20.2%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 29.8M USD +892%
Amortization of Intangible Assets 562K USD
Depreciation, Depletion and Amortization 521K USD +937%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 292K USD